Sfoglia per AUTORE
AGUGGIA M
Collezione ASL Asti

  

Items : 38

Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) in Journal of Headache and Pain

2025
ASL Asti

Barbanti P; Fiorentini G; Camarda C; Autunno M; Pistoia F; Aurilia C; d’Onofrio F; Egeo G; Carnevale A; Caproni S; Doretti A; Cherchi A; De Simone R; Zucco M; Rinalduzzi S; Colombo B; Filippi M; Quintana S; Russo M; Coppola A; Grugno R; Bartolini M; Viticchi G; Rao R; Albanese M; Vernieri F; Grazzi L; Robotti M; Di Summa A; et alii...

The Second Exteroceptive Suppression Period of the Temporalis Muscle Is Altered in Migraine Patients with Allodynia in Neurology International

2025
ASL Asti

Rota E; Immovilli P; Aguggia M; Saracco MG; Ghiglione E; Melotti A; Morelli N;

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1505-1506. doi: 10.1007/s40120-024-00648-z.

2024
ASL Asti

Barbanti P; Egeo G; Proietti S; d'Onofrio F; Aurilia C; Finocchi C; Di Clemente L; Zucco M; Doretti A; Messina S; Autunno M; Ranieri A; Carnevale A; Colombo B; Filippi M; Tasillo M; Rinalduzzi S; Querzani P; Sette G; Forino L; Zoroddu F; Robotti M; Valenza A; Camarda C; Borrello L; Aguggia M; Viticchi G; Tomino C; Fiorentini G; et alii...

Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2434-2443. doi: 10.1007/s00415-023-12103-4. Epub 2024 Jan 17.

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D'Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2444-2445. doi: 10.1007/s00415-024-12287-3.

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D'Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Jun;13(3):611-624. doi: 10.1007/s40120-024-00591-z. Epub 2024 Mar 7.

2024
ASL Asti

Barbanti P; Egeo G; Proietti S; d'Onofrio F; Aurilia C; Finocchi C; Di Clemente L; Zucco M; Doretti A; Messina S; Autunno M; Ranieri A; Carnevale A; Colombo B; Filippi M; Tasillo M; Rinalduzzi S; Querzani P; Sette G; Forino L; Zoroddu F; Robotti M; Valenza A; Camarda C; Borrello L; Aguggia M; Viticchi G; Tomino C; Fiorentini G; et alii...

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) in Journal of Neurology

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D’Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) in Journal of Neurology

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D’Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study (Journal of Neurology, (2024), 271, 5, (2434-2443), 10.1007/s00415-023-12103-4) in Journal of Neurology

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D’Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study. in The journal of headache and pain / J Headache Pain. 2023 Mar 23;24(1):30. doi: 10.1186/s10194-023-01561-w.

2023
ASL Asti

Barbanti P; Egeo G; Aurilia C; Torelli P; Finocchi C; d'Onofrio F; d'Onofrio L; Rao R; Messina S; Di Clemente L; Ranieri A; Autunno M; Sette G; Colombo B; Carnevale A; Aguggia M; Tasillo M; Zoroddu F; Frediani F; Filippi M; Tomino C; Proietti S; Bonassi S;

Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study in European Journal of Neurology

2023
ASL Asti

Vernieri F; Brunelli N; Marcosano M; Aurilia C; Egeo G; Lovati C; Favoni V; Perrotta A; Maestrini I; Rao R; d'Onofrio L; Finocchi C; Aguggia M; Bono F; Ranieri A; Albanese M; Di Piero V; Cevoli S; Altamura C; Barbanti P; Costa CM; Fofi L; Di Cola FS; d’Onofrio F; Bertuzzo D; Bombardieri F; Messina R; Colombo B; Filippi M; et alii...

Change in the second exteroceptive suppression period of the temporalis muscle during erenumab treatment. in Naunyn-Schmiedeberg's archives of pharmacology / Naunyn Schmiedebergs Arch Pharmacol. 2022 May;395(5):607-611. doi: 10.1007/s00210-022-02216-4. Epub

2022
ASL Asti
ASL Alessandria

Renosio D; Morelli N; Immovilli P; Aguggia M; Rota E; Barbanera A;

Late response to anti-CGRP (calcitonin gene-related peptide) monoclonal antibodies: implication for clinical practice in European Journal of Neurology

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Altamura C; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Finocchi C; Di Fiore P; Zucco M; Trimboli M; Bonassi S; Vernieri F; Barbanti P;

Predictors of response to antiCGRP monoclonal antibodies: a multicenter, 24-week, cohort study on 864 migraine patients in European Journal of Neurology

2022
ASL Asti
ASL Vercelli

Egeo G; Aurilia C; Cevoli S; Fiorentini G; Altamura C; Finocchi C; Di Clemente L; Zucco M; Raniero A; Trimboli M; Bono F; Filippi M; Proietti S; Bonassi S; Le Pera D; Albanese M; Grazzi L; Di Fiore P; D'Onofrio F; Aguggia M; Colombo B; Torelli P; Vernieri F; Barbanti P;

Late response to anti-CGRP monoclonal antibodies occurs in one-third of migraine patients in Headache

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Torelli P; Salerno A; Albanese M; Carnevale A; d'Onofrio F; Finocchi C; Altamura C; Aguggia M; Mercuri B; Bono F; Grazzi L; D'Amico D; Filippi M; Colombo B; Frediani F; Favoni V; Di Fiore P; Bertuzzo D; Zucco M; Di Clemente L; Trimboli M; Proietti S; Bonassi S; Vernieri F; et alii...

Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients in Journal of Headache and Pain

2022
ASL Asti

Barbanti P; Egeo G; Aurilia C; Altamura C; d’Onofrio F; Finocchi C; Albanese M; Aguggia M; Rao R; Zucco M; Frediani F; Filippi M; Messina R; Cevoli S; Carnevale A; Fiorentini G; Messina S; Bono F; Torelli P; Proietti S; Bonassi S; Vernieri F;

Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience in Journal of Neurology

2022
ASL Asti

Altamura C; Brunelli N; Marcosano M; Aurilia C; Egeo G; Lovati C; Favoni V; Perrotta A; Maestrini I; Schiano Di Cola F; d’Onofrio F; Finocchi C; Bertuzzo D; Bono F; Ranieri A; Albanese M; Messina R; Doretti A; Di Piero V; Cevoli S; Barbanti P; Vernieri F; Costa CM; Fofi L; Rao R; d’Onofrio L; Spitalieri D; Aguggia M; Bombardieri F; et alii...

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study in European Journal of Neurology

2022
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Lovati C; Bertuzzo D; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Schiano Di Cola F; Ranieri A; Colombo B; Bono F; Albanese M; Cevoli S; Barbanti P; Pierangeli G; Capogrosso C; Aguggia M; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; et alii...

Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia. in Journal of neural transmission (Vienna, Austria : 1996) / J Neural Transm (Vienna). 2021 Jun;128(6):869-870. doi: 10.1007/s00702-020-02262-3.

2021
ASL Città di Torino
ASL Asti

Tinazzi M; Erro R; Mascia MM; Esposito M; Ercoli T; Ferrazzano G; Di Biasio F; Pellicciari R; Eleopra R; Bono F; Bertolasi L; Barone P; Scaglione CLM; Pisani A; Altavista MC; Cotelli MS; Ceravolo R; Cossu G; Zibetti M; Coletti Moja M; Girlanda P; Maderna L; Albanese A; Petracca M; Magistrelli L; Misceo S; Minafra B; Romano M; Squintani GM; et alii...

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in real-life in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Egeo G; Fofi L; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Fiore PD; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in reallife in Journal of Headache and Pain

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) in Journal of Headache and Pain

2021
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Pierangeli G; Lovati C; Aguggia M; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Rao R; Bono F; Ranieri A; Albanese M; Cevoli S; Barbanti P; Capogrosso C; Bertuzzo D; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; Di Cola FS; et alii...

GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: A multicenter prospective cohort study (the GARLIT study) in Cephalalgia

2021
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Pierangeli G; Lovati C; Aguggia M; Bertuzzo D; D'Onofrio F; Doretti A; Di Fiore P; Frediani F; Finocchi C; Rao R; Schiano Di Cola F; Bono F; Ranieri A; Albanese M; Cevoli S; Barbanti P;

Demographic and clinical determinants of neck pain in idiopathic cervical dystonia. in Journal of neural transmission (Vienna, Austria : 1996) / J Neural Transm (Vienna). 2020 Oct;127(10):1435-1439. doi: 10.1007/s00702-020-02245-4. Epub 2020 Aug

2020
ASL Città di Torino
ASL Asti

Tinazzi M; Erro R; Mascia MM; Esposito M; Ercoli T; Ferrazzano G; Di Biasio F; Pellicciari R; Eleopra R; Bono F; Bertolasi L; Barone P; Scaglione CLM; Pisani A; Altavista MC; Cotelli MS; Ceravolo R; Cossu G; Zibetti M; Moja MC; Girlanda P; Maderna L; Albanese A; Petracca M; Magistrelli L; Misceo S; Minafra B; Romano M; Squintani GM; et alii...

Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? in Parkinsonism & related disorders / Parkinsonism Relat Disord. 2020 Feb;71:40-43. doi: 10.1016/j.parkreldis.2020.01.002. Epub 2020 Jan 1

2020
ASL Città di Torino
ASL Asti

Defazio G; Fabbrini G; Erro R; Albanese A; Barone P; Zibetti M; Esposito M; Pellicciari R; Avanzino L; Bono F; Eleopra R; Bertolasi L; Altavista MC; Cotelli MS; Ceravolo R; Scaglione C; Bentivoglio AR; Cossu G; Coletti Moja M; Girlanda P; Misceo S; Pisani A; Mascia MM; Ercoli T; Tinazzi M; Maderna L; Minafra B; Magistrelli L; Romano M; et alii...

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Dec;41(Suppl 2):487-488. doi: 10.1007/s10072-020-04669-y.

2020
ASL Asti

Vernieri F; Altamura C; Aurilia C; Brunelli N; Egeo G; Fofi L; Costa CM; Fallacara A; Favoni V; Pierangeli G; Aguggia M; Bertuzzo D; Albanese M; Di Fiore P; Frediani F; Cevoli S; Barbanti P;

Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials. in Frontiers in neurology / Front Neurol. 2020 Dec 15;11:576272. doi: 10.3389/fneur.2020.576272. eCollection 2020.

2020
ASL Asti

Giovanardi CM; Cinquini M; Aguggia M; Allais G; Campesato M; Cevoli S; Gentili F; Matrà A; Minozzi S;

Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry. in Frontiers in neurology / Front Neurol. 2020 Aug 26;11:906. doi: 10.3389/fneur.2020.00906. eCollection 2020.

2020
ASL Città di Torino
ASL Asti

Di Biasio F; Marchese R; Abbruzzese G; Baldi O; Esposito M; Silvestre F; Tescione G; Berardelli A; Fabbrini G; Ferrazzano G; Pellicciari R; Eleopra R; Devigili G; Bono F; Santangelo D; Bertolasi L; Altavista MC; Moschella V; Barone P; Erro R; Albanese A; Scaglione C; Liguori R; Cotelli MS; Cossu G; Ceravolo R; Coletti Moja M; Zibetti M; Pisani A; et alii...

New evidence from the italian chronic migraine registry (iron registry): An update on 866 patients in Neurology

2020
ASL Asti

Barbanti P; Fofi L; Egeo G; Aurilia C; Grazzi L; Vernieri F; Altamura C; Camarda C; Torelli P; Cevoli S; Russo A; Bono F; Finocchi C; Rao R; Messina S; De Simone R; D'Onofrio F; Aguggia M; Frediani F; Carnevale A; Autunno M; Lia C; Battista Allais G; Coppola A; Perini F; Balsamo P; Strumia S; Colombo B; Proietti S; et alii...

P031. An observational study on chronic tension-type headache treatment with Quantum Molecular Resonance according to I.A.R.A. model(®). in The journal of headache and pain / J Headache Pain. 2015 Dec;16(Suppl 1):A176. doi: 10.1186/1129-2377-16-S1-A176.

2015
ASL Asti

Gulotta F; Grazzi L; Allais GB; Rolando S; Saracco MG; Cavallini M; De Giorgio A; Padovan AM; Pelosin S; Agagliati P; Aguggia M;

Relationship between primary headache and nutrition: a questionnaire about dietary habits of patients with headache. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 May;35 Suppl 1:159-61. doi: 10.1007/s10072-014-1760-2.

2014
ASL Asti

Saracco MG; Calabrese G; Cavallini M; Montano V; Rinaldi B; Valfrè W; Aguggia M;

Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 May;35 Suppl 1:115-9. doi: 10.1007/s10072-014-1752-2.

2014
ASL Asti

Saracco MG; Allais G; Tullo V; Zava D; Pezzola D; Reggiardo G; Omboni S; Benedetto C; Bussone G; Aguggia M;

The painful muse: migrainous artistic archetypes from visual cortex. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 May;35 Suppl 1:51-5. doi: 10.1007/s10072-014-1773-x.

2014
ASL Asti

Aguggia M; Grassi E;

Post operative delirium with hyponatriemia after transurethral resection of the prostate: a case of transurethral resection syndrome? in Acta neurologica Belgica / Acta Neurol Belg. 2011 Jun;111(2):152-4.

2011
ASL Asti

Cavallini M; Saracco MG; Aguggia M;

Pathophysiology of migraine chronification. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2010 Jun;31 Suppl 1:S15-7. doi: 10.1007/s10072-010-0264-y.

2010
ASL Asti

Aguggia M; Saracco MG;

Greater occipital nerve block in chronic migraine. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2010 Jun;31 Suppl 1:S179-80. doi: 10.1007/s10072-010-0320-7.

2010
ASL Asti

Saracco MG; Valfrè W; Cavallini M; Aguggia M;

Local therapies in migraine. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2009 May;30 Suppl 1:S67-70. doi: 10.1007/s10072-009-0072-4.

2009
ASL Asti

Aguggia M;